![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Nuclear Medicine |
Free Subscription
2 Brain |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Nuclear Medicine is free of charge.
Determinants of cognitive and brain resilience to tau pathology: a longitudinal
analysis.
Brain. 2023;146:3719-3734.
PubMed
Abstract available
Genetically identical twin-pair difference models support the amyloid cascade
hypothesis.
Brain. 2023;146:3735-3746.
PubMed
Abstract available
Evaluating infusion methods and simplified quantification of synaptic density in
vivo with [(11)C]UCB-J and [(18)F]SynVesT-1 PET.
J Cereb Blood Flow Metab. 2023 Sep 5:271678X231200423.
PubMed
Abstract available
ASNC model coverage policy: 2023 cardiac positron emission tomography.
J Nucl Cardiol. 2023 Sep 5. doi: 10.1007/s12350-023-03355.
PubMed
Multimodality Imaging of Aortic Valve Calcification and Function in a Murine
Model of Calcific Aortic Valve Disease and Bicuspid Aortic Valve.
J Nucl Med. 2023;64:1487-1494.
PubMed
Abstract available
Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI
Radioligand Therapy.
J Nucl Med. 2023;64:1449-1455.
PubMed
Abstract available
CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell
Tumors.
J Nucl Med. 2023;64:1424-1430.
PubMed
Abstract available
Single-Time-Point Imaging for Dosimetry After [(177)Lu]Lu-DOTATATE: Accuracy of
Existing Methods and Novel Data-Driven Models for Reducing Sensitivity to
Time-Point Selection.
J Nucl Med. 2023;64:1463-1470.
PubMed
Abstract available
New Developments in Myeloma Treatment and Response Assessment.
J Nucl Med. 2023;64:1331-1343.
PubMed
Abstract available
The Future of Nuclear Medicine.
J Nucl Med. 2023;64:1329-1330.
PubMed
Response to "Critique and Discussion of 'Multicenter Evaluation of Frequency and
Impact of Activity Infiltration in PET Imaging, Including Microscale Modeling of
Skin-Absorbed Dose'".
J Nucl Med. 2023 Sep 7:jnumed.123.266596. doi: 10.2967/jnumed.123.266596.
PubMed
Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with
(177)Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis.
J Nucl Med. 2023 Sep 7:jnumed.122.265155. doi: 10.2967/jnumed.122.265155.
PubMed
Abstract available
Impact of (68)Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of
226 Patients with Various Cancers.
J Nucl Med. 2023 Sep 7:jnumed.123.266046. doi: 10.2967/jnumed.123.266046.
PubMed
Abstract available
Evaluation of treatment response by Hopkins criteria on18F FDG PET-CT in patients
of non-small cell lung cancer and its comparison with PERCIST response criteria.
Nucl Med Commun. 2023 Sep 4. doi: 10.1097/MNM.0000000000001756.
PubMed
Abstract available
Identifying and troubleshooting the pitfalls of ictal/interictal brain perfusion
SPECT studies.
Nucl Med Commun. 2023 Sep 4. doi: 10.1097/MNM.0000000000001755.
PubMed
Abstract available
PET/CT imaging fibroblast activation protein in initial colorectal cancer:
compared to 18F-FDG PET/CT.
Nucl Med Commun. 2023 Sep 4. doi: 10.1097/MNM.0000000000001751.
PubMed
Abstract available
PET-Derived Increased Inflammation in Large Vessels is linked to Relapse-Free
Survival in Patients with Giant Cell Arteritis.
Nuklearmedizin. 2023;62:229-234.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by